NCA
IONS icon

NCM Capital Advisers’s Ionis Pharmaceuticals IONS Stock Holding History

NCM Capital Advisers’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-14,200
Closed -$817K – 95
2015
Q2 		$817K Hold
14,200
– – 1.09% 39
2015
Q1 		$904K Sell
14,200
-500
-3% -$33.9K 1.22% 30
2014
Q4 		$908K Buy
14,700
+300
+2% +$14.8K 1.27% 28
2014
Q3 		$559K Buy
14,400
+8,150
+130% +$289K 0.84% 54
2014
Q2 		$215K Sell
6,250
-9,450
-60% -$298K 0.32% 86
2014
Q1 		$678K Sell
15,700
-15,400
-50% -$746K 1.07% 42
2013
Q4 		$1.24M Buy
31,100
+6,150
+25% +$219K 1.28% 26
2013
Q3 		$937K Buy
+24,950
New +$745K 1.04% 42

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

NCM Capital Advisers's IONS Position: Q3 2015 in Review

NCM Capital Advisers sold out of Ionis Pharmaceuticals (IONS) in Q3 2015, closing a stake of 14,200 shares — an estimated $817K sold.

NCM Capital Advisers first reported a position in IONS in Q3 2013 and held it in 8 quarters. The position peaked at $1.24M in Q4 2013. 314 funds tracked by Wall St. Rank hold IONS as of Q3 2015.

  • NCM Capital Advisers reported no remaining Ionis Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • NCM Capital Advisers sold 14,200 Ionis Pharmaceuticals shares in Q3 2015, an estimated $817K.
  • NCM Capital Advisers first reported a position in Ionis Pharmaceuticals in Q3 2013 and held it in 8 quarters.
  • NCM Capital Advisers's Ionis Pharmaceuticals position peaked at $1.24M in Q4 2013.
  • 314 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2015.

Based on NCM Capital Advisers's 13F filing for Q3 2015, filed 4 Nov 2015.